vinit6675's blog

Market Overview

The Global Liquid Biopsy Market 2020 is poised to mature at a 28.0% CAGR and is estimated to acquired USD 17.38 billion by 2027. 

Market Dynamics

The global demand for liquid biopsy is ruled on a rising understanding of personalized cancer treatment. The industry is powered by the demand for non-invasive tests, rising cancer incidence, and robust cancer detection and treatment research and growth. Also, the market is powered by many liquid biopsies advantages such as fast diagnosis, detection of unique mutations, low cost, and less labor needed. Growing information about the diagnosis of different cancer types often drives business development. Also, new screening and therapeutic methods need to be implemented because of the growing incidence of rare cancer and the late diagnosis of the diseases. Thus, late diagnosis reduces the chance of curing the disease as it spreads all over the body. The technology is further applicable to cardiac and neurological disease monitoring, early detection and drug resistance assessment, and prenatal testing. It can now be applied to monitoring organ transplants to bridge the gap between the need for new technology and the increasing demand.

However, tumor heterogeneity, which remains the most significant challenge in cancer research, may restrain the market growth.

Market Segmentation

The global liquid biopsy market has been segmented into biomarker types, applications, samples, and end-user. 

Based on biomarker types, the global market is segmented into extracellular vesicles (EVS), circulating tumor DNA (CTDNA), circulating tumor cells (CTCS), and others.

Based on the application, the global market has been segmented into cancer, reproductive health, and others.

Based on the sample, the global market is segmented into blood samples, urine samples, forensic, and other samples.

Based on the end-users, the global market is segmented into academic and research centers, hospitals and laboratories, and other end users. The other driving factors for the commercial application of the technology were advances in detection technologies such as advanced cell capture technology, digital PCR, and multi-panel detection.

Regional Study

On the healthcare market, depending on the area, the global liquid biopsy is segmented into North America, Europe, Asia-Pacific, and Middle East & Africa.

North America accounted for 37.95 percent of the highest market share in 2016, and Asia-Pacific is the fastest developing region. Liquid biopsy technology has been developed in the US and several European countries, resulting in the domination of these two regions in their respective market share. The European economy is forecast to expand by 28.5 percent at the fastest CAGR. Around 2001 to 2010, the venture funding available to life science companies more than doubled. The UK accounts for nearly 20 percent of all investments in Europe, and nearly 20 percent of UK venture capital has been spent in the healthcare sector. Asia-Pacific is the fastest-growing region and is projected to rise over the forecast period at a CAGR of 29.7 percent. It is expected the Middle East & Africa will have a limited market but steady growth. Africa, Asia-Pacific, and Latin America account for almost two-thirds of the incidents and three-fourths of the deaths.

Competitive Dashboard

The major players in the global liquid biopsy market are SAGA Diagnostics AB (Sweden), Guardant Health, Inc. (US), Inivata Ltd (UK), Trovagene, Inc. (California), Biocept, Inc. KGaA (US), RainDance Technologies, Inc. (the US), Admera Health (US), Agena Bioscience Inc. (California), Circulogene Theranostics (Alabama), and Exosome Diagnostics (Massachusetts).

The market's leading players concentrate on creating innovative testing methods and technologies, as well as multiple strategic initiatives, including acquisitions, alliances, and cooperation. Fundraising for cancer treatment is one of the core challenges for the industry players to create innovative medical techniques and innovations as well as to sustain their market place.


Acknowledging the exponential growth records, the market is posting continually, Market Research Future (MRFR), in its recently published analysis report asserts that the global Appendicitis market will witness significant accruals by 2023 registering 4.2% CAGR throughout the forecast period (2017 – 2023). The improving economic conditions worldwide, define the growth that the appendicitis market perceives today, enabling access to the quality of life & to the improved healthcare.

Technological advancement transpired into medical science is a key driving force pushing up the growth of the market bringing about advanced diagnostic and treatment procedures. Moreover, the increasing emphasis on early diagnosis of the disease defines the market landscape.  Furthermore, the increasing occurrences of appendicitis along with the rising demand for diagnostic and treatment options of appendicitis support the market growth.

On the flip side, factors such as the unmet medical needs and drug resistance restrict market growth, up to some extent. Nevertheless, technological advancements expected to take place soon are expected to support market growth throughout the forecast period, advancing medical devices.

Global Appendicitis Market – Segmentations

The MRFR analysis is segmented into five key dynamics for enhanced understanding.

By Type                                : Acute, And Chronic Appendicitis

By Diagnosis     : Physical Examination, White Blood Cell Count, Urinalysis, and Imaging Test among others.

By Treatment    : Antibiotics and Appendectomy among others.

By End-user                        : Hospitals & Clinics, Diagnostic Centers, and others.

By Regions                          : North America, Asia Pacific,Europe, and the Rest-of-the-World.

Appendicitis Market - Regional Analysis

The North American region, heading with the rising prevalence of acute appendicitis accounts for the leading market for appendicitis treatment.  Factors such as the Presence of major medical device manufacturers, pharmaceutical companies, and well-developed healthcare industry positively impacts the growth of the regional market.

Technological advancements in the burgeoning healthcare industry are providing new effective drugs for treatments that can give better outcomes, and this is one of the key factors driving the growth of the regional market. Furthermore, the rising awareness about appendicitis and the availability of its treatment, and availability of emergency diagnostic services foster the market growth in the region.

The appendicitis market in the European region holds the next largest share in the global market, owing to the resurging economy that is availing the best possible healthcare and increasing the healthcare expenditures. Germany, France, and the U.K backed by the increasing demand for the technological advanced diagnostic devices account for the major contributors to the Europe appendicitis market.

The well-developed healthcare sector and the notable pharmaceutical companies that are engaged in R&D activities for the development of new drugs to treat appendicitis are some of the key driving forces behind the growth of the regional market. Additionally, government support is fostering the market growth in the region, encouraging the market players to develop effective therapeutics.

Whereas, the Asia Pacific appendicitis market is growing rapidly, emerging as a promising market, globally owing to the introduction of new & advanced diagnostic options such as CT scan. The rising demand for specialty healthcare services in emerging countries such as India has fuelled the growth of the regional market.

Also, factors such as the ever-increasing population and the integration of advanced technologies in the healthcare sector are propelling the growth of the regional market. Asian countries especially, India and China provide immense growth opportunities for the appendicitis market, accounting for the considerable investment in R&D activities for prognostic treatments and drug formulation.

Global Appendicitis Market   - Competitive Analysis

Highly competitive, the appendicitis market appears to be widely expanded and fragmented characterized by several small and large-scale companies operating the market. Matured players incorporate strategic initiatives such as partnership, acquisition, collaboration, product launch, and expansion, gaining a competitive advantage and thus maintaining their positions in this market.

These players ensure their mission success, focusing on optimizing situational awareness towards customers. They invest substantially in the R&D and clinical trials to develop breakthrough treatment procedures and drugs. To maximize their efficiency in the process and operations, key players are focusing on developing a bettered method, a diagnostic and treatment-response of the disease.

Industry/Innovation/ Related News:

January 15, 2019 ---A group of scientists from the different universities of Izmir, Turkey including Department of Pediatric Surgery, Izmir Katip Celebi University, and Department of Microbiology, Ataturk Education & Research Hospital, Turkey, published their study on Pentraxin-3, a strong novel biochemical marker for appendicitis in children in the American Journal of Emergency Medicine. 

Researchers investigated the diagnostic values of pentraxin-3/PTX-3 in pediatric appendicitis and compared it with the other serum parameters.

In this study, these researchers have shown that PTX-3 is very useful with high specificity and sensitivity in the diagnosis of appendicitis compared to ANS, WBC, NLR, and CRP as a first in the literature.


The thyroid gland is known to regulate many functions in the body, and in the event of a disorder in the thyroid gland, the domino effect impacts various other bodily functions. Market focused reports linked with the healthcare industry among others recently have been made available by Market Research Future which issues reports on this industry. The market for thyroid disorder is predicted to achieve revenues worth US$2400.8 million by 2022 while developing with a CAGR of 3.1 percent approximately in the forecast period.

The disorders related to the thyroid hormone cause fluctuations in the level of release of the thyroid hormones. The fluctuations need to monitored and controlled by way of medication and certain lifestyle changes. Functions such as fertility, cardiac functions, and kidney functions are among those critical body functions that are affected by the thyroid disorders. Increasing awareness about thyroid disorders and growing access to medical assistance has increased the growth pace of the market. The rise of alternative medicines is also expected to positively boost the progress of the market in the forecast period.

Industry Segments

The thyroid disorder market globally has been segmented on the disease indication, basis of treatment, end users, route of administration, and region. The basis of treatment segments the market into diagnostics, surgery, drugs, and supplements. The basis of disease indication segments the market into hyperthyroidism, hypothyroidism and other. The segmentation based on the route of administration segments the market into injectable, oral and others. The end users segmentation of the market is segmented into home use and hospitals. The regions included in the market are APAC, Middle East, and Europe, Americas, Africa and rest of the world.

Detailed Regional Analysis

The regional analysis of the thyroid disorder market includes regions such as APAC, Middle East, and Europe, Americas, Africa and rest of the world. Among all the regions, America is the principal market for thyroid disorder, and Europe is the second biggest market. The established regions are expected to lose their market leadership in the future owing to the emerging Asia Pacific region which is projected to be the most swiftly growing region in thyroid disorder market. Nations such as India and China will control this region. The African region is likely to be a moderately increasing market in the thyroid disorder market globally.

Global Competitive Analysis

The prospects for growth and innovation have amplified at a rapid pace transforming the market. Engaging and converting prospective opportunities is modifying the growth pace of the market considerably. The stimulus for the market’s growth has changed the competitive backdrop of the market. By making certain supply and demand are in balance, the competitors can reveal new opportunities for growth. The competitors in the market have been encouraged to plan strategic road-maps that capitalize on the positive market cues. The prominent trends and players have led to a positive tone for development. The important trends and players have established a positive tone for development.

A few of the major players in this market are Abbott Laboratories, Allergan, Merck & Co., Inc., GlaxoSmithKline plc, Pfizer Inc., RLC LABS, AbbVie, Mylan, and others.

Industry Updates:

Feb 2018 The Central Marine Fisheries Research Institute (CMFRI) is all set to launch a natural product from the sea to tackle thyroid disorder after having developed nutraceutical products to treat diabetes, arthritis, and cholesterol from marine organisms such as seaweeds and green mussel. The marine nutraceutical product made by the Institute for thyroid dysfunction is in the final stage of clinical trial. The four nutraceutical products made by the CMFRI in the past has witnessed a huge demand in the healthcare market.


As per the latest published report by Market Research Future (MRFR), the global cardiac rehabilitation devices market is expected to attain a compound annual growth of 6% during the forecast period between 2017 and 2023. The Global Cardiac Rehabilitation Devices Market segmentation is classified based on end-user and type.

Cardiac Rehabilitation Devices are used for improving the health condition of patients that are diagnosed with various heart-related disorders like congestive heart failure, cardiovascular disease, etc. The device is also used for patients who have undergone any form of heart surgery like bypass surgery or angioplasty. Cardiac rehabilitation aids in improving the quality of life by reducing the cardiac symptoms, which then provides benefits like long-term survival, blood pressure, improves cholesterol level, lowers the blood sugar level, blood pressure, and reduces the stress level.

Market Segmentation

The Global Cardiac Rehabilitation Devices Market segmentation is classified on the basis of end-user and type.

By type, the market includes ellipticals, stationary bicycle, heart rate monitors, recumbent cross trainer, blood flow monitors, training balls, treadmill, and others.

By end-user, the market segments into specialty centers, hospitals and clinics, rehab centers, and others.

By region, the market covers North America, Europe, Asia Pacific, and the Middle East and Africa.

Regional Analysis

Geographically, the North American region holds the maximum share in the global cardiac rehabilitation devices market. The North American regional market is divided further into the US and Canada. The growing old-age population and widespread prevalence of cardiovascular disorders are two of the key factors stimulating the growth of the market in this region. Also, growing healthcare expenditure, growing demand for technologically advanced treatments and products, increasing number of approvals for cardiovascular diseases, and the rising support from the government are all likely to contribute to the overall growth of the market in this region.

Europe holds the second largest share of the market and contributes significantly to the global market. The European region is forecasted to experience consistent growth in the forthcoming years. This is due to the growing healthcare expenditure, availability of new and advanced treatment facilities, and an imperative need for better healthcare infrastructure. Add to this, factors like rising cardiovascular rates and an increasing inclination towards sedentary lifestyle by a majority of the population. The region is also expected to grow due to the rising patient population as well.

Asia Pacific is expected to be potentially the fastest growing regional market. Herein, the growing prevalence of chronic diseases is one of the major drivers behind the growth of the market. Rising health consciousness, availability of new methods of treatment, improving living standards, and the growing healthcare expenditure drive the market in this region. China contributes significantly to the overall Asia Pacific market and is expected to be the fastest growing country due to the vast population base that would lead to increasing patient population.

The Middle East and Africa region hold the least growth potential in the forthcoming years due to lack of awareness therein and a poor healthcare landscape. However, the United Arab Emirates is identified to be the largest growing nation in this region due to the developing healthcare industry and the proliferating availability of specialty care centers.

Competitive Landscape

The Global Cardiac Rehabilitation Devices Market comprises various leading and prominent players, including Amer Sports,LifeWatch AG, Ball Dynamics International, LLC, The ScottCare Corporation, Mortara Instrument, Core Health and Fitness LLC, Vonco Medical, and others.

April 11th, 2019, a research conducted recently revealed that it is completely safe and secure for patients to return back to their workplace post heart attack. The research was published in the European Journal of Preventive Cardiology.


Ultrasound gastroscopes are endoscopy equipment used by surgeons in the diagnosis and treatment of gastrointestinal (GI) disorders. The global ultrasound gastroscopes market report by Market Research Future (MRFR) contains trends and growth drivers pertinent to its future which have been compiled by looking at historical data and current events.

Market Outlook

The global ultrasound gastroscopes market is expected to register a CAGR of 6.32% over the forecast period (2018-2023). It stood at USD 630.2 million in 2017. Technological breakthroughs in endoscopy equipment and the transformation of the healthcare sector are likely to drive the market growth.

Rising prevalence of gastric cancers and biopsies of gastroscopic samples as well as collection of images of blood flow for ascertaining the presence of malignant tumors can bode well for the market. According to the National Cancer Institute, close to 26,420 cases of stomach cancer were detected in the U.S. in 2017.

Segmentation Analysis

The global ultrasound gastroscopes market has been segmented into product type, application, procedure, and end user.

The market on the basis of product type has been segmented into endoscopic ultrasound needle, optic ultrasound gastroscope, linear array ultrasound gastroscope, and others.

Based on application, the market has been segmented into oncology, pancreatic conditions, and others. Further, the oncology segment has been segmented into upper gastrointestinal (GI) oncology and lower gastrointestinal (GI) oncology.

On the basis of procedure, the global market has been segmented into upper endoscopy ultrasound (EUS), lower endoscopy ultrasound (EUS), and others.

Based on end user, the market is segmented into hospitals and clinics, ambulatory surgical centers, and others.

Regional Analysis

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is expected to be the leading region of the global ultrasound gastroscopes market due to massive demand for minimally invasive therapies in oncology, availability of advanced products in the U.S., and rising prevalence of stomach cancer. According to the Canadian Cancer Society, close to 3,500 Canadians were diagnosed with the disease. Gastroscopes can play its part by detecting the disease at a preventive stage.

Europe can capture a sizeable share of the market during the assessment period. This can be attributed to rising incidence of GI diseases and the large geriatric population. Establishment of the European Society of Gastrointestinal Endoscopy (ESGE) for keeping surgeons and doctors aware of the latest developments in gastroenterology and imaging techniques can bode well for the market. This can encourage sales of the latest gastroscopes at private and government hospitals.

APAC is touted to exhibit a rapid growth rate till 2023 due to investments in the healthcare sector, large patient pool, and developments in gastroscopes. Heightened demand for new treatments in South Korea and India can fuel the market growth in the region. Lastly, the MEA region has the lowest market share due to lack of sufficient infrastructure and paucity of efficient treatments.

Competition Outlook

Cook Medical, Karl Storz Endoscopy, Esaote Spa, Medi-Globe GmbH, Medtronic plc, Olympus Corporation, Fujifilm Holdings, Boston Scientific Corporation, and Conmed Corporation are major industry participants. The competition in the market is marked by collaborations and product launches driven by technological advances.


The rise in cases of diabetes globally is encouraging the progress of the smart biosensor market. The innovations in the monitoring systems are expected to bolster the market’s growth in the forecast period. Also, the surge in R&D spending and collective strategies are inspiring the smart biosensor market in the imminent period.

Segmental Analysis

The segmentation assessment of the smart biosensors market has been segmented on the basis of application, product type, technology, region, and end-user. Based on the product type, the smart biosensors market has been segmented into non-wearable biosensors and wearable biosensors. Based on technology, the smart biosensor market is segmented into piezoelectric biosensors, electrochemical biosensors, optical biosensors, Nano mechanical biosensors, thermal biosensors, and others. The smart biosensor market on the application has been segmented into cholesterol testing, blood glucose testing, blood gas analysis, drug discovery, pregnancy testing, infectious disease testing, and others. The end-user segment in the smart biosensor market has been segmented into home diagnostics, point-of-care, research labs, environmental monitoring, security & biodefense, food & beverage industry, and others. By region, the smart biosensor market is segmented into the Asia Pacific, the Americas, Europe, and the Middle East & Africa.

Detailed Regional Analysis   

The regional evaluation of the smart biosensor market perceives that Americas region is anticipated to hold the highest portion of smart biosensors market due to the increasing occurrence of chronic disorders, promising policies applied by government and regulatory authorities, and the application of highly progressive technology. The European region market is expected to be the second major smart biosensors market. The market development in this region can be accredited to the incidence of the well-established healthcare system in the region, government plans for directing chronic disorders, and an upsurge in the population experiencing from cardiovascular disorders. The Asia Pacific region is likely to be the fastest increasing smart biosensors market throughout the forecast period owing to the rising occurrence of diabetes, growing disposable income, and government schemes for the expansion of the healthcare sector. The market in the Middle East & Africa is anticipated to hold the minimum share of the smart biosensors market due to a small healthcare sector, absence of technical knowledge, and deprived medical facilities.

Competitive Analysis

The profitability in the market is enhanced significantly by the existence of strong strategies deployed by market players. The identification and use of apposite media channels are expected to transform the market development in the coming years. The market is ushering in a phase of development that is expected to be motivated by the positive factors in the market. The demographics present in the market present a favorable outlook in terms of product expansion and future growth potential. The strategies in the market are being aimed at improving the overall progress of the market, with the business models taking into account all contingencies that may arise in the coming years. The pull created by the businesses in the market by positioning marketing policies and events is additionally growing the development of the market. The improvement of production resources is likely to stimulate the market’s improvement in the forecast period.

The main players in the smart biosensors market are Medtronic IncSiemens Healthcare AG, Lifescan, Inc., Abbott Point of Care Inc., LifeSensors Inc., Pharmaco-Kinesis Corporation, Nova Biomedical Corp., F. Hoffman La-Roche Ltd., Acon Laboratories Inc., Universal Biosensors, Biacore, and others.


Besides, quality communication among all members of a healthcare team improves patient safety by reducing the number of mistakes. For instance, if a physician knows the patient’s full medical history, including procedures or prior conditions, it helps that physician prescribe a safe, effective treatment for that patient. If someone confuses the terminology, putting the wrong condition or procedure into the chart, this can make a huge difference in the care the patient receives. Treatment may be less effective, or in some cases, dangerous.

With the rising need for providing laboratory operators with enhanced inventory control and tracking, medical terminology software market is expected to gain massive traction. The market will also accrue proceeds from the greater demand for flexibility to address changing needs of laboratory and medical business.

Medical terminology is a basis for effective communication in the medical world. When everyone uses the same terms for understanding a condition, procedure and medicine, delivering care or billing for a medicine becomes more efficient and effective. Standard medical terminology is also the backbone for training and communication, infection control training and HIPAA compliance training that create a safe environment for both patients and employees.


The medical terminology software market is segmented as product & service, application, and end user.

On the basis of product & service, medical terminology software market is subdivided into services and platforms.

By application, subsegments of medical terminology software market include data integration, data aggregation, public health surveillance, reimbursement, clinical guidelines, clinical trials, decision support and quality reporting.

End user medical terminology software market segment includes healthcare providers, IT vendors and healthcare payers. Healthcare providers subsegment is further divided into health information exchanges and healthcare service providers. Healthcare payers subsegment is also further subdivided into public payers and private payers.

Regional Analysis:

Increased demand for enhanced data exchange between healthcare providers and healthcare payers to streamline workflows is expected to place the Americas in a leading position in the global medical terminology software market share.

Europe, which share a similar position with North America in the healthcare industry has also witnessed increased requirement to maintain data integrity and is thus anticipated to hold the second largest share in the medical terminology software market.

Asia Pacific is expected to witness exponential growth in medical terminology software market share and emerge as the fastest growing region as far as the market is concerned.

The uptake of medical terminology software in Middle East and Africa, especially in the countries where healthcare industry and technologies are still lagging far behind than those in the modernized world, will be much slower. The region has witnessed fewer government initiatives and is therefore expected to hold the least share in the medical terminology software market.

Competitive Landscape:

Some of the key players in the medical terminology software market include, Intelligent Medical Objects, Wolters Kluwer, Clinical Architecture, Apelon, B2i Healthcare, Bitac, BT Clinical Computing, HiveWorx and CareCom.

Industry News:

Growth trends that are predicted to be apparent in the medical terminology software market can be fathomed by the success of some of the companies that play a critical role in upholding the industry. Thus, an announcement by Intelligent Medical Objects previously in 2016 that it has secured growth capital investment from funds affiliated with Warburg Pincus can be measured as a positive indication for the growth of the overall medical terminology software market.

Warburg Pincus is a global private equity firm that specializes in growth investing and its investment in Intelligent Medical Objects was planned to drive the expansion of the company and its work in health information ecosystem. A glimpse of the outcome of the investment is reflected in the 2019 relocation of the company headquarters to a massive 350,000-square-foot, complex in Rosemont, Illinois.


Market Analysis

Various factors are adding to the global veterinary clostridium vaccine market share. The different veterinary clostridium vaccine market drivers, as per the new MRFR report, include rising consumption of products that are animal-derived, technological advances, increasing prevalence if clostridium family diseases, growing awareness about zoonotic diseases, and rise in disposable income. On the other hand, the rising consumption of milk and meat are impacting the human vaccines market.

On the contrary, strict regulations, high treatment costs, and certain side effects are factors that may limit the global animal clostridium vaccine market growth over the forecast period.

The global veterinary clostridium vaccine market was valued USD 461.7 million in 2017 and is predicted to grow at a 4.5% CAGR between 2018- 2023, reveals the new Market Research Future (MRFR) report. Clostridium bacteria are anaerobic in nature. They are mostly found in the gut of animals and humans, and in soil. Vaccination plays a pivotal part in protecting animals against this disease. Generally, these vaccines are used for animals like poultry, caprine, swine, ovine, bovine, and others. Such vaccines come in different varieties, including combinations and single vaccines. The combination vaccines comprise toxoids, bacterins, or a mixture of toxoids and bacterins.

Regional Analysis

The veterinary clostridium vaccine market in Europe is predicted to possess the second-largest share over the forecast period for the growing awareness about various veterinary clostridium vaccine products, growing awareness about zoonotic diseases, and increasing demand for livestock products. The UK and Germany are the key contributors in the region.

The veterinary clostridium vaccine market in the APAC region is predicted to grow at a fast pace over the forecast period for increased government initiatives, growing population in India & China that is boosting the demand for meat products, increasing incidence of clostridial diseases, rise in disposable income, and growing awareness regarding clostridium vaccine products.

The veterinary clostridium vaccine market in the MEA is predicted to have the smallest share over the forecast period.

Key Players

Eminent players profiled in the global veterinary clostridium vaccine market report include Bayer AG (Germany), Elanco Animal Health (US), Zoetis (US), Valneva SE (France), Virbac (Australia), Colorado Serum Company (US), Boehringer Ingelheim International GmbH (Germany), Ceva Santé Animale (France), and Merck & Co., Inc. (US). Key players have incorporated strategies such as contracts, geographic expansions, mergers and acquisitions, product launches, and strategic alliances, among others, to create a niche in the market and also cater to customers growing needs.


Market Highlights

The increase in number of veterinary practitioners and rapid development of veterinary healthcare infrastructure can promote the market in the near future. Increase in rate of zoonotic diseases creating the demand for veterinary equipment market can improve impetus of the veterinary market. On the downside, lack of cognizance about animal health, expensiveness of veterinary equipment, and unaffordability of veterinary services can restrain expansion of the veterinary equipment and disposables market.

The global veterinary equipment and disposables market report by Market Research Future (MRFR) reveals that the worldwide veterinary equipment and disposables market can value at USD 1.63 Mn at about 14.70% CAGR by 2023. Across 2018 to 2023, the veterinary equipment and disposables industry 2020 can surge owing to causes, such as; rise in demand for pet insurance and hike in animal health expenditure.

Market Segmentation

The segment assessment for the worldwide veterinary equipment and disposables market are done on the basis of end user, type, and animal type.

The type-based segments of the veterinary equipment and disposables market are anesthesia equipment, critical care consumables, research equipment, fluid management equipment, temperature management equipment, and rescue and resuscitation equipment. The sub-segments of the critical care consumables segment are fluid administration and therapy consumables, wound management consumables, needles, airway management consumables, and gastroenterology consumables among others. The sub-segments of the anesthesia equipment are vaporizers, anesthesia machines, ventilators, gas delivery management systems, and waste gas management systems among others. The sub-segments of the research equipment segment are induction chambers and lab evacuation systems. The sub-segments of the rescue and resuscitation equipment segment are oxygen masks and resuscitation bags.

The animal type-based segments of the veterinary equipment and disposables market are large animals and small animals. The increase in adoption for companion animal can favor market.

The end user-based segments of the veterinary equipment and disposables market are research institutes, veterinary clinics, and veterinary hospitals among others. The veterinary clinics segment can expand at decent pace.

Regional Analysis

North America to secure decent veterinary equipment and disposables market share by 2023.In Europe, the increase in awareness about different vet medicines and introduction of initiatives promoting animal can have positive impact on the regional market. In APAC, the introduction of new animal care products and strategic collaborations among key players can strengthen growth of the market in the region.

In the Americas, the market can dominate with high CAGR, likely to be headed by the US. The growth of the veterinary equipment and disposables market in the region can be credited to surge in per increase in product innovation, hike in per capita animal healthcare expense, and penetration of disruptive technology.

In Europe, the market for veterinary equipment and disposables can thrive due to the existence of well-established healthcare system and the availability of effective insurance coverage for pets. In Asia Pacific, the presence of expert veterinarians and rise in animal care centers can contribute significantly to the market surge. Emergence of new markets and the availability of growth opportunities for players can also support veterinary equipment and disposables market in APAC. In the Middle East and Africa, the veterinary equipment and disposables market can exhibit moderate rise due to low disposable income.

Key Players

Smiths Group plc, B. Braun Melsungen AG, Digicare Biomedical Technology Inc., DRE Medical, Henry Schein, Jorgensen Labs, Medtronic, Patterson Companies, Inc., Midmark Corporation, and Vetland Medical Sales & Services are some of the key players that are analyzed by MRFR for the global veterinary equipment and disposables market research.


Market Analysis

The global surgical drills market is predicted to grow at a 4.93% CAGR over the forecast period (2017-2023), states the latest Market Research Future (MRFR) report. A surgical drill, simply put, is a device used for boring holes in bone for attaching screws, plates, or surgical pins or reshaping teeth and removing decay for a filling. These precision instruments help to accommodate different drill bits for catering an array of applications in anything from neurological to dental surgeries. Surgical drills have an extensive range of applications, including ENT, dental surgeries, neurosurgery, orthopedic surgery, and much more.

Various factors are propelling the surgical drills market growth. Some of these factors according to the Market Research Future report, include rising medical tourism, growing elderly population, changing lifestyle, changing eating habits of consumers, excessive alcohol consumption, rising number of dental and orthopedic surgeries, and rising awareness about dental hygiene. Additional factors pushing market growth include high disposable income, increasing prevalence of chronic diseases which need surgical procedures, upgrading of healthcare equipment and infrastructure, and constant development in surgical drill technology.

On the contrary, scarcity of skilled medical professional and severe government regulations are factors that may restrict the surgical drills market growth over the forecast period.

Market Segmentation

The MRFR report offers a wide segmental analysis of the surgical drills market on the basis of application, product, and end user.

Based on products, the surgical drills market is segmented into accessories, battery-powered drills, electric drills, pneumatic drills, and others. Of these, the pneumatic drills segment will have the largest share in the market over the forecast period.

Based on application, the surgical drills market is segmented into dental surgery, ENT, neurosurgery, orthopedic surgery, and others. Of these, the orthopedic surgery segment will dominate the market over the forecast period.

Based on end users, the surgical drills market is segmented into academic and research institutes, ambulatory surgical centers, hospitals and clinics, and others. Among these, the hospitals and clinics segment will lead the market over the forecast period.

Regional Analysis

Based on the region, the surgical drills market report covers the latest trends and growth opportunities across Europe, the Asia Pacific, the Americas, and the Middle East and Africa. Of these, the Americas will lead the market over the forecast period. This is owing to developed healthcare infrastructure, high physician and patient awareness about efficiency and safety of surgical drills, and an increasing number of orthopedic surgeries. Moreover, increasing awareness regarding dental hygiene, advanced treatment procedures, high disposable income, and state-of-the-art medical infrastructure are also boosting the market growth in this region.

The surgical drills market in Europe is predicted to have the second-largest share in the market over the forecast period. This is chiefly due to the rising support from the government for device manufacturers.

The surgical drills market in the APAC region is predicted to grow at the fastest pace over the forecast period. This is owing to increase in medical tourism, rising awareness among people about healthcare and surgical devices, improved healthcare infrastructure, growing medical sector, rise in government funding for healthcare, increasing medical device companies, and rising research and development expenditure.

The global surgical drills market in the Middle East and Africa is predicted to have minor growth over the forecast period.

Key Players

Leading players profiled in the surgical drills market report include Zimmer Biomet Holdings, Inc., Stryker Corporation, Medtronic plc, DePuy Synthes, De Soutter Medical, CONMED Corporation, B.Braun Melsungen AG, AlloTech Co.Ltd. Arthrex Inc., and Adeor medical AG, among others.

March 2019: The SMARTdrill 6.0 is now available in the US for common orthopedic surgical techniques. Its innovative technology will help in addressing the problem of drilling bone as well as placing screws by offering real-time drilling data to the surgeon for selecting implant hardware and informing their clinical decisions. This technology will prove beneficial to insurance companies and healthcare systems which are seeking to improve patient outcomes and reducing costs.


Pages: 1 2 3 4 5 ... » »»